表皮生长因子受体
非小细胞肺癌
癌症研究
无进展生存期
表皮生长因子受体抑制剂
作者
Makoto Maemondo,Tatsuro Fukuhara,Haruhiro Saito,Naoki Furuya,Kana Watanabe,Shunichi Sugawara,Shunichiro Iwasawa,Yoshio Tsunezuka,Ou Yamaguchi,Morihito Okada,Kouzou Yoshimori,Ichiro Nakachi,Akihiko Gemma,Koichi Azuma,Koichi Hagiwara,Toshihiro Nukiwa,Satoshi Morita,Kunihiko Kobayashi
标识
DOI：10.1200/jco.2020.38.15_suppl.9506
摘要
9506Background: In NEJ026, a phase III trial comparing bevacizumab plus erlotinib (BE) to erlotinib monotherapy (E) for EGFR-mutated non-small-cell lung cancer (NSCLC), we demonstrated the progress...
科研通智能强力驱动
Strongly Powered by AbleSci AI
爱静静
持卿
bc
nenoaowu
MchemG
迷人秋烟
科研小民工
Oracle
laber
back you up
weining
mufulee
GrindSeason
从容芮
suibianba
Leon
坚强的广山
搜集达人
劲秉
高大凌寒
皖公网安备34019202002308
